rs3212359

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000555427.1(MC1R):​c.-408-82C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.439 in 234,560 control chromosomes in the GnomAD database, including 25,068 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.45 ( 16512 hom., cov: 34)
Exomes 𝑓: 0.42 ( 8556 hom. )

Consequence

MC1R
ENST00000555427.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.48

Publications

15 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 16-89918769-C-T is Benign according to our data. Variant chr16-89918769-C-T is described in ClinVar as Benign. ClinVar VariationId is 321402.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.631 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124903759XM_047435031.1 linkc.1213-82C>T intron_variant Intron 3 of 3 XP_047290987.1
MC1RNM_002386.4 linkc.-490C>T upstream_gene_variant ENST00000555147.2 NP_002377.4 Q01726Q1JUL4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MC1RENST00000555427.1 linkc.-408-82C>T intron_variant Intron 2 of 3 5 ENSP00000451760.1 G3V4F0
MC1RENST00000639847.1 linkc.-408-82C>T intron_variant Intron 2 of 2 5 ENSP00000492011.1 Q01726
MC1RENST00000555147.2 linkc.-490C>T upstream_gene_variant 6 NM_002386.4 ENSP00000451605.1 Q01726

Frequencies

GnomAD3 genomes
AF:
0.449
AC:
68232
AN:
152036
Hom.:
16484
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.595
Gnomad AMI
AF:
0.298
Gnomad AMR
AF:
0.511
Gnomad ASJ
AF:
0.339
Gnomad EAS
AF:
0.651
Gnomad SAS
AF:
0.552
Gnomad FIN
AF:
0.442
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.332
Gnomad OTH
AF:
0.430
GnomAD4 exome
AF:
0.421
AC:
34680
AN:
82406
Hom.:
8556
Cov.:
0
AF XY:
0.419
AC XY:
15924
AN XY:
37982
show subpopulations
African (AFR)
AF:
0.593
AC:
2241
AN:
3778
American (AMR)
AF:
0.549
AC:
1736
AN:
3164
Ashkenazi Jewish (ASJ)
AF:
0.341
AC:
1718
AN:
5036
East Asian (EAS)
AF:
0.795
AC:
8970
AN:
11278
South Asian (SAS)
AF:
0.529
AC:
453
AN:
856
European-Finnish (FIN)
AF:
0.463
AC:
37
AN:
80
Middle Eastern (MID)
AF:
0.481
AC:
232
AN:
482
European-Non Finnish (NFE)
AF:
0.328
AC:
16724
AN:
51004
Other (OTH)
AF:
0.382
AC:
2569
AN:
6728
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
863
1727
2590
3454
4317
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.449
AC:
68310
AN:
152154
Hom.:
16512
Cov.:
34
AF XY:
0.457
AC XY:
34009
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.595
AC:
24685
AN:
41508
American (AMR)
AF:
0.512
AC:
7836
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.339
AC:
1178
AN:
3470
East Asian (EAS)
AF:
0.650
AC:
3357
AN:
5166
South Asian (SAS)
AF:
0.551
AC:
2654
AN:
4818
European-Finnish (FIN)
AF:
0.442
AC:
4687
AN:
10600
Middle Eastern (MID)
AF:
0.568
AC:
167
AN:
294
European-Non Finnish (NFE)
AF:
0.332
AC:
22563
AN:
67972
Other (OTH)
AF:
0.431
AC:
912
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1871
3741
5612
7482
9353
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.421
Hom.:
2141
Bravo
AF:
0.460
Asia WGS
AF:
0.564
AC:
1965
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.43
DANN
Benign
0.86
PhyloP100
-3.5
PromoterAI
-0.060
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212359; hg19: chr16-89985177; COSMIC: COSV59624817; COSMIC: COSV59624817; API